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Abstract
C3H10T1/2, a mouse mesenchymal stem cell line, is a well-known in vitro model of chondrogenesis that can be easily 
employed to recapitulate some of the mechanisms intervening in this process. Moreover, these cells can be used to validate 
the effect of candidate molecules identified by high throughput screening approaches applied to the development of targeted 
therapy for human disorders in which chondrogenic differentiation may be involved, as in conditions characterized by hetero-
topic endochondral bone formation. Chondrogenic differentiation of C3H10T1/2 cells can be monitored by applying quanti-
tative polymerase chain reaction (qPCR), one of the most sensitive methods that allows detection of small dynamic changes 
in gene expression between samples obtained under different experimental conditions. In this work, we have used qPCR to 
monitor the expression of specific markers during chondrogenic differentiation of C3H10T1/2 cells in micromass cultures. 
Then we have applied the geNorm approach to identify the most stable reference genes suitable to get a robust normalization 
of the obtained expression data. Among 12 candidate reference genes (Ap3d1, Csnk2a2, Cdc40, Fbxw2, Fbxo38, Htatsf1, 
Mon2, Pak1ip1, Zfp91, 18S, ActB, GAPDH) we identified Mon2 and Ap3d1 as the most stable ones during chondrogenesis. 
ActB, GAPDH and 18S, the most commonly used in the literature, resulted to have an expression level too high compared 
to the differentiation markers (Sox9, Collagen type 2a1, Collagen type 10a1 and Collagen type 1a1), therefore are actually 
less recommended for these experimental conditions. In conclusion, we identified nine reference genes that can be equally 
used to obtain a robust normalization of the gene expression variation during the C3H10T1/2 chondrogenic differentiation.
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Introduction
C3H10T1/2 cells are a mouse cell line functionally similar to 
mesenchymal stem cells [1] that can be induced to differenti-
ate towards chondrocyte, osteoblast and adipocyte lineages 
when cultured in presence of specific culture media [2–4]. 
In particular, these cells represent an established cellular 
model to simulate in vitro chondrogenesis, because they do 
not spontaneously differentiate under normal culture con-
ditions, but can be induced by cellular condensation (high 
density micromass culture) and treatment with bone mor-
phogenetic protein 2 (BMP2) [3, 5–8].
Due to limitations of primary cell lines and complex-
ity of animal models, in the last decades, various in vitro 
cellular models with chondrogenic capabilities have been 
established to have cost effective, reproducible and simple 
experimental systems available to study the mechanisms that 
underlie chondrogenesis [8]. These in vitro models can be 
successfully applied also to recapitulate some of the crucial 
events that might be deregulated in pathological conditions.
Fibrodysplasia Ossif icans Progressiva (FOP, 
MIM135100) is one of the most severe and disabling dis-
order due to extra-skeletal ossification (heterotopic ossi-
fication, HO). The disease is caused by mutations of the 
ACVR1 gene encoding a type I receptor for bone morpho-
genetic proteins (BMPs), and is characterized by ectopic 
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bone formation affecting skeletal muscles, ligaments and 
tendons [9, 10]. Early FOP lesions are characterized by local 
inflammatory response, muscle degeneration and fibro-pro-
liferative reaction, followed by mesenchymal condensation, 
chondrogenesis and bone neoformation. Therefore, carti-
lage differentiation can be considered a crucial step in FOP 
pathogenesis. Regarding the origin of cells undergoing the 
aberrant differentiation process, the source of the progeni-
tors involved is still actively investigated and debated, and 
according to recent studies is likely to be heterogeneous 
[11–15].
So far, no specific treatment is available to cure FOP and 
prevent the occurrence of the ossification flares. However, 
in the last years many effort have been devoted to study the 
cellular and molecular mechanisms altered in the disease and 
the advancements of the research in the field has provided 
targets to develop specific therapies by both drug discovery 
or drug repositioning approaches (for a revision see [11, 
16]).
In vitro cellular models like C3H10T1/2 cells represent 
an essential tool to evaluate compounds identified by high 
throughput screening (HTS) of large collections of small 
molecules to find out candidate “hits” to be further devel-
oped as targeted therapy in diseases in which chondrogenesis 
represents a crucial step as in FOP. Indeed, primary screen-
ings provide a list of candidate molecules that need to be 
validated in reliable secondary assays to confirm their effect 
on defined targets and to investigate pathways involved in 
their activity.
The progression of chondrogenic differentiation in 
C3H10T1/2 micromass cultures can be monitored by apply-
ing specific histological stainings such as Alcian Blue or 
Toluidin Blue, able to detect the deposition of extra-cellular 
matrix glycosaminoglycans; or by verifying the expression 
of differentiation markers through immunohistochemical 
assays with specific antibodies; by using quantitative real-
time PCR (qPCR) to evaluate changes in the expression of 
differentiation markers at different stages of the process.
qPCR is definitely one of the most sensitive methods that 
allows detection of small dynamic changes in gene expres-
sion between samples, therefore it is mandatory to proceed 
with extreme care in every step of the process, from sample 
preparation to data interpretation.
MIQE (minimum information for publication of quantita-
tive real-time PCR experiments) guidelines help to define 
the most important steps from RNA to qPCR to minimize 
errors and the minimum set of information required to evalu-
ate the reliability of qPCR data [17]. According to these 
guidelines, after accurate evaluation of RNA quality and 
cDNA synthesis, it is essential to rely on the use of solid 
reference genes. Moreover, it is highly recommended to use 
at least two different reference genes in order to normalize 
the expression of mRNA under analysis.
Nevertheless, few studies report a systematic screening 
of panels of reference genes before the choice of the best 
candidates to be used in relationship to the cell type, differ-
entiation stage and experimental conditions [18]. Very fre-
quently, only a single gene is applied to normalize, and the 
most commonly used remain Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), β-actin (ActB) and 18S ribosomal 
RNA also in C3H10T1/2 differentiation studies [19–21].
Reference genes stability can be evaluated by several 
methods. The most popular rely on the use of dedicated 
programs such as geNorm [22], BestKeeper [23], and Nor-
mFinder [24] that are based on different algorithms, but all 
evaluate the variance in Cq values (quantification cycle, 
the cycle at which fluorescence from amplification exceeds 
the background fluorescence) of candidate reference genes 
across different samples, cell types, experimental conditions, 
etc.
In the current work, PrimerDesign  geNormPLUS kit was 
employed to screen a panel of 12 reference genes in order 
to select the best candidates to be applied in monitoring the 
chondrogenic differentiation process in C3H10T1/2 cells.
To this aim, C3H10T1/2 were cultured in the appropriate 
conditions to induce chondrogenesis and used to select the 
best reference genes to obtain a reliable expression profile of 




C3H10T1/2 cells were purchased from ATCC cell biology 
collection (C3H/10T1/2, Clone 8, ATCC® CCL-226™). 
Cells were used between the 5th and 15th passage and were 
routinely cultured in complete medium consisting of MEM 
with Earle’s Salts (Euroclone® S.p.a) supplemented with 
10% fetal bovine serum (FBS, Gibco, ThermoFisher Sci-
entific), 2 mM Glutamine, 100 U/ml Penicillin, 0.1 mg/ml 
Streptomycin (Euroclone® S.p.a). Cells were cultured at 
37 °C in a humidified atmosphere with 5%  CO2.
C3H10T1/2 and chondrocyte‑like differentiation
In order to induce chondrocyte-like differentiation, micro-
mass cultures were obtained as described by Denker et al., 
1999 [3]. Briefly, cells were trypsinized and  107 cells/
ml were resuspended in Ham’s F12 medium with 10% 
fetal bovine serum. 10 µl drop of cell suspension was 
placed in the center of a well in a standard 24-well plate 
(Euroclone® S.p.a). The cells were allowed to adhere for 
2–3 h at 37 °C and 5%  CO2, and then 500 µl of medium 
3479Molecular Biology Reports (2019) 46:3477–3485 
1 3
containing 100 ng/ml of BMP2 (Peprotech) was added to 
each well. Medium was replaced every 3 days.
To check chondrocyte differentiation, cells were either 
processed for RNA extraction or for Alcian Blue stain-
ing to verify glycosaminoglycans deposition. To this aim, 
micromass cultures were rinsed with Dulbecco’s phos-
phate-buffered saline (DPBS without Ca and Mg, Euro-
clone® S.p.a), fixed for 10 min in 4% Paraformaldehyde 
solution (Santa Cruz Biotechnology, Inc.) and stained 
overnight with a mixture containing 0.05% w/v Alcian 
Blue 8GX (Sigma-Aldrich), 0.2 M sodium acetate buffer, 
pH5.8 and 0.5 M  MgCl2.
Quantitative PCR primers
In this study, we used the Mouse  geNormPLUS kit (Prim-
erDesign) that includes a list of 12 reference genes (Ap3d1, 
Csnk2a2, Cdc40, Fbxw2, Fbxo38, Htatsf1, Mon2, Pak1ip1, 
Zfp91, 18S, ActB, GAPDH) selected for their high sta-
bility level in different biological samples and treatment 
conditions. Oligonucleotides detect all the transcript vari-
ants and are PrimerDesign proprietary information (See 
Table S1 for accession numbers and anchor nucleotide of 
the assays). Primers sequences of the other genes used in 
this work are shown below and were selected from the 
literature [25, 26] to produce mouse-specific amplicons. 
Primer sequences: Sox9, Fwd GAG CCC GAT CTG AAG 
AAG GA, Rev GCT TGA CGT GCG GCT TGT TC (151 bp, 
[25]); Collagen type 2a1, (Col2a1) Fwd CAC CAA ATT 
CCT GTT CAG CC, Rev TGC ACG AAA CAC ACT GGT 
AAG (124 bp, [25]); Collagen type 10a1, (Col10a1) Fwd 
TTC TGC TGC TAA TGT TCT TGACC, Rev GGG ATG AAG 
TAT TGT GTC TTGGG (115 bp, [26]); Collagen type 1a1, 
(Col1a1) Fwd ATG CCG CGA CCT CAA GAT G, Rev TGA 
GGC ACA GAC GGC TGA GTA (153 bp, [26]).
RNA extraction and cDNA synthesis
Total RNA was isolated from T0, T1, T3, T6 and T13 
time points by using the RNeasy Plus Mini kit (Qiagen) 
according to the manufacturers’ protocol. RNA quality and 
concentration were established by electrophoresis on 1% 
Agarose gel (Fig S1) and by nanodrop spectrophotometer 
(ThermoFisher Scientific). All RNA samples displayed 
260/280 ratios > 2.0 and first strand cDNA was obtained 
from 1 µg RNA, using the iScript reverse transcription 
supermix for RT-qPCR (Bio-Rad), according to the manu-
facturers’ instructions. cDNA preparations were diluted 
six-fold prior to quantitative PCR analysis.
Quantitative PCR (qPCR)
Gene expression profiles were evaluated through qPCR 
using the SYBER Green system, (IQ™ SYBER® Green 
Supermix, Bio-Rad). Reactions were prepared in duplicate 
in 20 µl volumes using 5 µl of diluted cDNA (around 25 ng 
cDNA assuming 1:1 synthesis) per well. qPCR was per-
formed on the IQ5 instrument from Bio-Rad with the follow-
ing protocol: 95 °C for 3 min, 40 amplification cycles: dena-
turation at 95 °C for 30 s, annealing at 60 °C for 30 s and 
extension at 72 °C for 40 s. The presence of single specific 
amplification product was checked by melting curve analysis 
and template-free controls in all runs performed. All samples 
were quantified in the same run for a given reference gene 
and reaction efficiencies were estimated by standard dilution 
curve and analysis of individual traces.
Quantification cycle (Cq) values for each replicate reac-
tion were extracted from IQ5 analysis and analyzed through 
the  qBasePLUS software (Biogazelle, https ://www.qbase plus.
com/) to calculate geNorm values. Details about geNorm 
algorithm are described in Vandesompele et al., 2002 [22]. 
Relative expression of differentiation markers was calculated 
by the ∆Ct Method, derived as a modification of the  2−∆∆Ct 
(Livak) approach [27]. The applied ∆Ct Method uses the 
difference between reference and target Ct values for each 
sample, (Ratio (reference/target) = 2 Ct(reference)−Ct(target)).
Statistical analysis
The results obtained from reference genes study were ana-
lyzed by the  qBasePLUS software (Biogazelle). Experiments 
to evaluate gene expression profile by qPCR were performed 
from three independent biological replicates and the results 
were represented as average ± Standard Deviation of gene 
relative expression. The unpaired two-tailed Student’s t-test 
(GraphPad, https ://www.graph pad.com/quick calcs /ttest 1) 
was applied to verify statistical significance of the observed 
variation. Significant variations were defined as *P < 0.05.
Results
Chondrogenic differentiation of C3H10T1/2
C3H10T1/2 micromass cell cultures were induced to differ-
entiate with BMP2, starting from day 1 to day 13. In order 
to evaluate the differentiation process, micromass cultures 
were stained with Alcian Blue, specific for the deposition of 
the matrix glycosaminoglycans, after 1, 3, 6, and 13 days of 
culture in inductive medium (Fig. 1). The expression level 
of markers associated with chondro-differentiation and car-
tilage formation (Sox9, Col2a1, Col10a1 and Col1a1) was 
also monitored (Fig. S2).
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Study of 12 candidate reference genes
In parallel, cells cultured in the same conditions and blocked 
at the different time points were used to identify the best 
reference genes suitable to study gene expression varia-
tion during differentiation of C3H10T1/2. RNA quality and 
concentration (Fig. S1) were checked for all the samples 
deriving from two different groups of experiments and the 
expression of a panel of 12 reference genes was evaluated. 
qPCR results were processed with the IQ5 software and Cq 
values were exported to be analysed with  qbase+ software 
(Table S2). Amplification efficiency, calculated from stand-
ard curves was between 1.9 and 2.10 for all genes, corre-
sponding to 90–110% which represents the recommended 
range (Table S1).
GeNorm study was applied following the instruction of 
the software. GeNorm M value represents reference gene 
stability and according to the geNorm manual, candidate 
genes with lower M value have to be considered more stable. 
The graph starts with the least stable gene on the left side 
and ends with the most stable gene on the right part, with a 
threshold of 0.5 between stable and unstable genes. There-
fore, all the tested reference genes appeared to be stable upon 
the different conditions and thus suitable for gene expression 
analysis at different time points of C3H10T1/2 chondrogenic 
differentiation (Fig. 2a). However, the best candidate refer-
ence genes identified were Mon2 and Ap3d1, whereas the 
less stable were ActB and GAPDH, curiously among the 
most commonly used in the literature. The geNorm V value 
suggests the minimum number of reference genes required 
for normalization. The threshold value is 0.15, below which 
the inclusion of an additional control is not required [22]. 
As shown in Fig. 2b, all the reference genes combination 
has  Vn/n+1 < 0.15 (n = optimal number of reference genes), 
suggesting that a combination of two reference genes was 
sufficient for a correct normalization.
Expression profile of the differentiation markers 
normalized against the different reference genes
To validate geNorm analysis and reference genes selection, 
C3H10T1/2 micromass cultures were harvested at time 0 and 
after 6 days of chondrogenic differentiation and processed for 
qPCR assay.
The expression level of markers associated with chon-
dro-differentiation and cartilage formation (Sox9, Col2a1, 
Col10a1) was obtained by the ∆Ct Method. In this evaluation, 
various reference genes were employed, including all single 
candidate reference genes, a combination of the most stable 
ones identified in this study, calculated by the geometric aver-
age of Mon2&Ap3d1, Ap3d1&Fbxw2, Mon2&Ap3d1&Fbxw2 
(indicated as M&A, A&F, M&A&F), and the geometric aver-
age of all 12 reference genes Ct values, (designed as ‘All’). 
As shown in Fig. 3 up-regulation of the chondrogenic genes 
Sox9, Col2a1, Col10a1 was demonstrated by all normalization 
strategies. As a control, we evaluated also the expression of 
Col1a1, a gene not associated with cartilage differentiation and 
expected to be downregulated in micromass cultures induced 
by BMP2 [28]. As shown in Fig. 3, the decrease in Col1a1 
expression upon differentiating conditions does not appear sig-
nificant when ActB is applied as normalizing gene, compared 
to ‘All’ and to other single or combined reference genes.
Comparison of relative expression of 12 candidate 
reference genes
In order to select the proper reference genes with transcription 
level similar to that of target genes, Ct values deriving from 
qPCR assay on RNA samples at T0 and T6, were normalized 
against Fbxo38, which showed the lowest expression level.
As reported in Fig. 4, relative expression of most of the ref-
erence genes have similar magnitude, whereas ActB, GAPDH 
and 18S showed the highest expression in C3H10T1/2 cells.
This analysis suggested the exclusion of ActB, GAPDH 
and 18S because their transcription levels were too far from 
that of target genes and this might affect the accuracy of the 
normalization process.
Discussion
qPCR is one of the most sensitive method to evaluate the 
expression level of genes of interest under different experi-
mental conditions, and thus in order to obtain reliable results 
it is crucial to select the suitable reference genes [26, 29–34].
Fig. 1  Chondrogenic differ-
entiation of C3H10T1/2 cells. 
Representative C3H10T1/2 
micromass cultures after 1, 3, 6 
and 13 days of BMP2 treatment. 
Cells were fixed and stained 
with Alcian blue. DM, differen-
tiation medium
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In the last years, several algorithms were developed to 
identify the optimal reference genes in different cell types/
tissues or treatment conditions. GeNorm [22], BestKeeper 
[23], and NormFinder [24] are the most frequently applied to 
this purpose and are reported to usually show similar results 
[35, 36].
To the aim of using C3H10T1/2 cells as an in vitro model 
of chondro-like differentiation [3], we applied the geNorm 
software to identify the most stable references genes suitable 
for normalization during the in vitro differentiation process 
of these cells. GeNorm has been developed according to the 
normalization strategy described by Vandesompele et al., 
2002 [22], conceived to identify the most stably expressed 
control genes in a given set of tissues, and to determine the 
minimum number of genes required to calculate a reliable 
normalization factor.
In our study, we used a commercial kit of 12 murine 
‘house-keeping’ genes, specifically designed by PrimerD-
esign for geNorm studies, and we performed two biological 
replicates of C3H10T1/2 chondrogenic differentiation after 
1, 3, 6, and 13 days.
The first parameter generated by the  geNormPLUS analysis 
is geNorm M, which evaluates expression stability of candi-
date reference genes between samples. M value represents 
the average pairwise variation of a particular gene with all 
the other control genes: the lowest M value indicates the 
most stable gene expression. The cut-off value is 0.5 and 
all the genes we analyzed in this study could be considered 
potential reference genes.
According to the MIQE guidelines, an accurate normali-
zation process relies on the use of two or more reference 
genes and geNorm V value (pairwise variation,  V(n/n+1) coef-
ficient) helps to determine the number of them required for 
optimal normalization. The suitable number of reference 
genes “n” is found when  V(n/n+1) drops below 0.15.
As shown in Fig. 2,  V2/3 was less than 0.15  (V2/3 = 0.082) 
and two reference genes were sufficient for a correct nor-
malization, ideally Mon2 and Ap3d1.
Fig. 2  GeNorm analysis of 
12 candidate reference genes. 
a geNorm M value indicates 
reference genes stability. The 
genes with geNorm M value 
below 0.5 can be considered for 
the normalization and the lower 
is the value, the more stable are 
the genes. b GeNorm V value 
represents the pairwise varia-
tion (n/n + 1) and indicates the 
minimum number of reference 
genes required for normaliza-
tion. Values below 0.15 indicate 
the optimal number (n) of refer-
ence genes to be considered. In 
this study, a combination of two 
genes was sufficient for a cor-
rect normalization,  V2/3 = 0.082
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Fig. 3  Fold-change expression 
of chondrogenic differentiation 
markers, normalized against 
different reference genes after 
6 days of differentiation. a 
Sox9, b Col2a1, c Col10a1, d 
Col1a1. Relative expression 
was calculated by ∆Ct Method 
and histograms represent 
average ± Standard Deviation 
of three independent biologi-
cal replicates. The statistical 
significance was evaluated by 
Student’s T-test analysis with 
*P < 0.05
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To validate geNorm analysis, we evaluated the expres-
sion levels of markers specific for chondrogenic differen-
tiation of C3H10T1/2 cells at T0 and after 6 days of micro-
mass culture in inductive medium containing BMP2. Sox9, 
Col2a1 and Col10a1 showed high expression level after 
BMP2 treatment and all normalization strategies showed 
comparable expression level. In particular, the combina-
tion of Mon2 and Ap3d1, Ap3d1 and Fbxw2, and Mon2, 
Ap3d1 and Fbxw2, gave similar results to the normaliza-
tion obtained with ‘All’, which is considered as the most 
accurate strategy.
Furthermore, it is known that for accurate gene expres-
sion studies the expression level of reference genes should 
be similar to that of target genes [26, 37]. Therefore, we 
compared the expression profile of all the 12 reference 
genes in our cell model. Our analysis suggested that ActB, 
GAPDH and especially 18S genes should not be consid-
ered for normalization because their expression level sig-
nificantly diverges from that of the selected differentiation 
markers in C3H10T1/2 cells.
Moreover, the use of ActB as reference gene failed to 
efficiently detect the expected down-regulation of Col1a1 
expression in differentiating conditions [28].
This result suggested the exclusion of ActB, one of the 
most applied in expression studies, from the best refer-
ence genes group, because during the evaluation of treat-
ment effects, also small gene expression differences may 
become relevant. All the other reference genes and com-
bination analysed in this work, showed similar expression 
levels and pass our validation.
Conclusions
qPCR is a potent method to study gene expression profiles 
in different experimental settings. Reliability of results is 
strongly dependent on the normalization procedure; refer-
ence genes have to be carefully selected for every tissue/
cell types and for the different experimental conditions. 
We applied the geNorm analysis to select the best refer-
ence genes in a widely used in vitro model of chondro-
genesis. According to our analysis, the most commonly 
used reference genes, such as ActB, GAPDH and 18S, 
are not actually the best candidates for normalization. 
We suggest to use a different combination of at least two 
genes selected from the panel we tested, such as Mon2 and 
Ap3d1 when normalizing gene expression profiles during 
chondrogenesis in C3H10T1/2 cells.
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Fig. 4  Relative expression of 
the 12 reference genes. Cells 
were analysed after 6 days of 
differentiation. Gene expression 
values were calculated using 
∆Ct Method against Fbxo38, 
that showed the lowest expres-
sion. Histograms represent 
average and standard deviation 
of three independent biological 
replicates. Y axis was on a  log10 
scale
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